Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - Shire plc | dp82340_ex9901.htm |
| 8-K - FORM 8-K - Shire plc | dp82340_8k.htm |
Exhibit 99.2
| Press Release |  |
| www.shire.com |
Director/PDMR Shareholding
November 1, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG)
Notification of transactions by persons discharging managerial responsibilities
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
| a) | Name | Flemming Ornskov | |
| 2. | Reason for the notification | ||
| a) | Position / status | Chief Executive Officer - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan. Dr. Ornskov has elected to save $480.76 per fortnight. The option price will be the lower of 85% of the fair market value of an ADS on October 31, 2017, and 85% of the fair market value of an ADS on October 30, 2018. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| N/A | N/A | ||
| d) |
Aggregated information - Aggregated volume - Price |
N/A (single transaction) | |
| e) | Date of the transaction | November 1, 2017 | |
| f) | Place of the transaction | N/A | |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
| a) | Name | Joanne Cordeiro | |
| 2. | Reason for the notification | ||
| a) | Position / status | Chief Human Resources Officer – PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan. Ms. Cordeiro has elected to save $480.76 per fortnight. The option price will be the lower of 85% of the fair market value of an ADS on October 31, 2017, and 85% of the fair market value of an ADS on October 30, 2018. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| N/A | N/A | ||
| d) |
Aggregated information - Aggregated volume - Price |
N/A (single transaction) | |
| e) | Date of the transaction | November 1, 2017 | |
| f) | Place of the transaction | N/A | |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
| a) | Name | Bill Mordan | |
| 2. | Reason for the notification | ||
| a) | Position / status | General Counsel and Company Secretary - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan. Mr. Mordan has elected to save $480.76 per fortnight. The option price will be the lower of 85% of the fair market value of an ADS on October 31, 2017, and 85% of the fair market value of an ADS on October 30, 2018. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| N/A | N/A | ||
| d) |
Aggregated information - Aggregated volume - Price |
N/A (single transaction) | |
| e) | Date of the transaction | November 1, 2017 | |
| f) | Place of the transaction | N/A | |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
| a) | Name | Perry Sternberg | |
| 2. | Reason for the notification | ||
| a) | Position / status | Head of US Commercial - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan. Mr. Sternberg has elected to save $480.76 per fortnight. The option price will be the lower of 85% of the fair market value of an ADS on October 31, 2017, and 85% of the fair market value of an ADS on October 30, 2018. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| N/A | N/A | ||
| d) |
Aggregated information - Aggregated volume - Price |
N/A (single transaction) | |
| e) | Date of the transaction | November 1, 2017 | |
| f) | Place of the transaction | N/A | |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
| a) | Name | Kim Stratton | |
| 2. | Reason for the notification | ||
| a) | Position / status | Head of International Commercial - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument |
Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)
| |
| Identification code | ISIN: JE00B2QKY057 | ||
| b) | Nature of the transaction | Receipt of option over notional Ordinary Shares granted under the Shire Global Employee Stock Purchase Plan. Ms. Stratton has elected to save Fr.1,007.25 per month. The option price will be the lower of 85% of the fair market value of an Ordinary Share on October 31, 2017, and 85% of the fair market value of an Ordinary Share on October 30, 2018. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| N/A | N/A | ||
| d) |
Aggregated information - Aggregated volume - Price |
N/A (single transaction) | |
| e) | Date of the transaction | November 1, 2017 | |
| f) | Place of the transaction | N/A | |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
| a) | Name | Matt Walker | |
| 2. | Reason for the notification | ||
| a) | Position / status | Head of Technical Operations – PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Receipt of option over notional ADSs granted under the Shire Global Employee Stock Purchase Plan. Mr. Walker has elected to save $480.76 per fortnight. The option price will be the lower of 85% of the fair market value of an ADS on October 31, 2017, and 85% of the fair market value of an ADS on October 30, 2018. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| N/A | N/A | ||
| d) |
Aggregated information - Aggregated volume - Price |
N/A (single transaction) | |
| e) | Date of the transaction | November 1, 2017 | |
| f) | Place of the transaction | N/A | |
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
| Investor Relations | ||
| Ian Karp | ikarp@shire.com | +1 781 482 9018 |
| Robert Coates | rcoates@shire.com | +44 203 549 0874 |
| Media | ||
| Lisa Adler | lisa.adler@shire.com | +1 617 588 8607 |
| Katie Joyce | kjoyce@shire.com | +1 781 482 2779 |
NOTES TO EDITORS
About Shire
Shire is the global leader in serving patients with rare diseases. We strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.
We feel a strong sense of urgency to address unmet medical needs and work tirelessly to improve people’s lives with medicines that have a meaningful impact on patients and all who support them on their journey.
www.shire.com